Skip to main content

Urachal and Non-urachal Adenocarcinomas of the Bladder

  • Chapter
  • First Online:
Rare Genitourinary Tumors

Abstract

Pure adenocarcinomas of the bladder are a very rare entity. It is important to understand the distinctions between the different types of adenocarcinomas that may be found in the bladder, as it may have an impact on their treatment. Urachal carcinomas, traditionally found in the midline or dome of the bladder, require a surgical procedure that is different from the typical cystectomy. Metastatic adenocarcinomas can occur from direct extension of local organs including the colon and rectum, from drop implants/peritoneal seeding from other adenocarcinomas of the abdominal cavity, and even from hematogenous metastases from primary sites both within and outside the abdominal cavity. Often, a careful medical history of previous cancer, clinical symptoms which are not typically associated with a bladder primary, and radiological findings suggestive of other potential primaries can aid in diagnosing a metastasis to the bladder. Adenocarcinomas of the urethra, which are addressed in a separate chapter, can also invade the bladder base and trigone secondarily. Only when none of these above findings are present should one consider the patient a true primary adenocarcinoma of the bladder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165–72.

    Article  CAS  PubMed  Google Scholar 

  2. Lughezzani G, Sun M, Jeldres C, et al. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Urology. 2010;75:376–81.

    Article  PubMed  Google Scholar 

  3. Smeulders N, Woodhouse CR. Neoplasia in adult exstrophy patients. BJU Int. 2001;87:623–8.

    Article  CAS  PubMed  Google Scholar 

  4. Allen TD, Henderson BW. Adenocarcinoma of the bladder. J Urol. 1965;93:50–6.

    CAS  PubMed  Google Scholar 

  5. Mostofi FK. Potentialities of bladder epithelium. J Urol. 1954;71:705–14.

    CAS  PubMed  Google Scholar 

  6. Mai KT, Yazdi HM, Perkins DG, et al. Multicentric clear cell adenocarcinoma in the urinary bladder and the urethral diverticulum: evidence of origin of clear cell adenocarcinoma of the female lower urinary tract from Mullerian duct remnants. Histopathology. 2000;36:380–2.

    Article  CAS  PubMed  Google Scholar 

  7. Zaghloul MS, Nouh A, Nazmy M, et al. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol. 2006;24:13–20.

    Article  PubMed  Google Scholar 

  8. Dayyani F, Czerniak BA, Sircar K, et al. Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. J Urol. 2013;189:1656–61.

    Article  PubMed  Google Scholar 

  9. Ro JY, Shen SS, Lee HI, et al. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2008;32:752–7.

    Article  PubMed  Google Scholar 

  10. Lopez-Beltran A, Luque RJ, Quintero A, et al. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003;442:381–7.

    CAS  PubMed  Google Scholar 

  11. Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25:1380–7.

    Article  CAS  PubMed  Google Scholar 

  12. Torenbeek R, Lagendijk JH, Van Diest PJ, et al. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998;32:20–7.

    Article  CAS  PubMed  Google Scholar 

  13. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–10.

    Article  PubMed  Google Scholar 

  14. Thomas AA, Stephenson AJ, Campbell SC, et al. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108–16.

    Article  CAS  PubMed  Google Scholar 

  15. El-Mekresh MM, El-Baz MA, Abol-Enein H, et al. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol. 1998;82:206–12.

    Article  CAS  PubMed  Google Scholar 

  16. Zaghloul MS, Abdel Aziz S. Primary adenocarcinoma of the urinary bladder: risk factors and value of postoperative radiotherapy. J Egypt Natl Canc Inst. 2003;15:193–200.

    Google Scholar 

  17. Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003;169:1295–8.

    Article  PubMed  Google Scholar 

  18. Galsky MD, Iasonos A, Mironov S, et al. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology. 2007;69:255–9.

    Article  PubMed  Google Scholar 

  19. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol. 1984;131:1–8.

    CAS  PubMed  Google Scholar 

  20. Wright JL, Porter MP, Li CI, et al. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 2006;107:721–8.

    Article  PubMed  Google Scholar 

  21. Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology. 1993;42:635–9.

    Article  CAS  PubMed  Google Scholar 

  22. Gupta S, Bhaijee F, Harmon EP. Mucinous neoplasm arising in a urachal cyst: a first in the pediatric population. Urology. 2014;83:455–6.

    Article  PubMed  Google Scholar 

  23. Sirintrapun SJ, Ward M, Woo J, et al. High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations. Hum Pathol. 2014;45:327–30.

    Article  CAS  PubMed  Google Scholar 

  24. Schubert GE, Pavkovic MB, Bethke-Bedurftig BA. Tubular urachal remnants in adult bladders. J Urol. 1982;127:40–2.

    CAS  PubMed  Google Scholar 

  25. Johnson DE, Hodge GB, Abdul-Karim FW, et al. Urachal carcinoma. Urology. 1985;26:218–21.

    Article  CAS  PubMed  Google Scholar 

  26. Siefker-Radtke A. Urachal adenocarcinoma: a clinician’s guide for treatment. Semin Oncol. 2012;39:619–24.

    Article  CAS  PubMed  Google Scholar 

  27. Takeuchi M, Matsuzaki K, Yoshida S, et al. Imaging findings of Urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei. Acta Radiol. 2004;45:348–50.

    Article  CAS  PubMed  Google Scholar 

  28. Ashley RA, Inman BA, Sebo TJ, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006;107:712–20.

    Article  PubMed  Google Scholar 

  29. Bruins HM, Visser O, Ploeg M, et al. The clinical epidemiology of urachal carcinoma: results of a large, population based study. J Urol. 2012;188:1102–7.

    Article  PubMed  Google Scholar 

  30. Herr HW, Bochner BH, Sharp D, et al. Urachal carcinoma: contemporary surgical outcomes. J Urol. 2007;178:74–8. discussion 78.

    Article  PubMed  Google Scholar 

  31. Molina JR, Quevedo JF, Furth AF, et al. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases. Cancer. 2007;110:2434–40.

    Article  PubMed  Google Scholar 

  32. Lane V. Prognosis in carcinoma of the urachus. Eur Urol. 1976;2:282–3.

    CAS  PubMed  Google Scholar 

  33. Kakizoe T. Adenocarcinoma of urachus. Report of 7 cases and review of literature. Urology. 1983;21:360–6.

    Article  CAS  PubMed  Google Scholar 

  34. Logothetis CJ, Samuels ML, Ogden S. Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C. Urology. 1985;26:252–5.

    Article  CAS  PubMed  Google Scholar 

  35. Siefker-Radtke AO, Millikan RE, Tu S-M, et al. Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2002;20:1361–7.

    Article  CAS  Google Scholar 

  36. Tannir NM, Thall PF, Ng CS, et al. A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents. J Urol. 2008;180:867–72. discussion 872.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tu SM, Hossan E, Amato R, et al. Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies. J Urol. 1995;154:1719–22.

    Article  CAS  PubMed  Google Scholar 

  38. Yanagihara Y, Tanji N, Miura N, et al. Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer. Chemotherapy. 2013;59:402–6.

    Article  CAS  PubMed  Google Scholar 

  39. Kojima Y, Yamada Y, Kamisawa H, et al. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy. Int J Urol. 2006;13:1123–5.

    Article  PubMed  Google Scholar 

  40. Kume H, Tomita K, Takahashi S, et al. Irinotecan as a new agent for urachal cancer. Urol Int. 2006;76:281–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arlene O. Siefker-Radtke MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Siefker-Radtke, A.O. (2016). Urachal and Non-urachal Adenocarcinomas of the Bladder. In: Pagliaro, L. (eds) Rare Genitourinary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-30046-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30046-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30044-3

  • Online ISBN: 978-3-319-30046-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics